Menu
Recruiting NCT06472804

Insomnia in Patients With Metastatic Lung Cancer

— Observational Metastatic Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Insomnia in Patients With Metastatic Non Small Cell Lung Cancer

Overview

This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.

Detailed description

PRIMARY OBJECTIVE:

I. Evaluate the frequency of insomnia in patients with metastatic non-small cell lung cancer.

OUTLINE: This is an observational study.

Patients undergo medical chart review and complete a questionnaire on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Frequency of clinically significant insomnia [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Have a diagnosis of metastatic non small cell lung cancer
  • Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy
  • Older than 18 years old at the time of diagnosis

Exclusion criteria

  • Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • Mayo Clinic in Rochester — Rochester

Identifiers

NCT: NCT06472804 · 19-001466 · NCI-2024-04893 · 19-001466

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗